METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug trial for pancreatic cancer halted early
Disease control TerminatedThis study tested a drug called niraparib as a first treatment for people with metastatic pancreatic cancer that has certain gene changes (HR-deficient). Only 2 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors, but results ar…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New drug cocktail aims to shrink liver tumors
Disease control TerminatedThis study tested a combination of three drugs—nivolumab, tadalafil, and vancomycin—in adults with liver cancer or liver tumors that spread from colorectal or pancreatic cancer. The goal was to see if the treatment could shrink tumors. The study was stopped early, but the results…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New hope for tough-to-treat pancreatic cancer? early trial tests combo approach
Disease control TerminatedThis early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) is safe and effective for people with metastatic pancreatic cancer. Only 4 participants were enrolled before the study was stopped. The goal was to find the right dose …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Experimental pancreatic cancer combo trial halted early
Disease control TerminatedThis early-stage trial tested whether adding the experimental drug YL-13027 to standard chemotherapy (gemcitabine and nab-paclitaxel) is safe for people with advanced pancreatic cancer that had stopped responding to prior treatment. Only 4 participants were enrolled before the st…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Can a pill stop cancer wasting? trial cut short
Symptom relief TerminatedThis study tested whether anamorelin, a daily pill, could help people with advanced pancreatic cancer avoid severe weight loss and loss of appetite during chemotherapy. The trial planned to enroll about 100 participants but was stopped early after only 4 people joined. The drug a…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated May 17, 2026 00:51 UTC